Rivernorth Capital Management’s Aimei Health Technology Co AFJK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-172,789
Closed -$1.83M 361
2024
Q4
$1.83M Hold
172,789
0.09% 165
2024
Q3
$1.81M Buy
172,789
+14,391
+9% +$150K 0.09% 158
2024
Q2
$1.64M Hold
158,398
0.08% 169
2024
Q1
$1.63M Buy
+158,398
New +$1.61M 0.08% 170

Other funds holding AFJK

Rivernorth Capital Management's AFJK Position: Q1 2025 in Review

Rivernorth Capital Management sold out of Aimei Health Technology Co (AFJK) in Q1 2025, closing a stake of 172,789 shares — an estimated $1.83M sold.

Rivernorth Capital Management first reported a position in AFJK in Q1 2024 and held it in 4 quarters. The position peaked at $1.83M in Q4 2024. 16 funds tracked by Wall St. Rank hold AFJK as of Q1 2025.

  • Rivernorth Capital Management reported no remaining Aimei Health Technology Co position as of Q1 2025 after selling out during the quarter.
  • Rivernorth Capital Management sold 172,789 Aimei Health Technology Co shares in Q1 2025, an estimated $1.83M.
  • Rivernorth Capital Management first reported a position in Aimei Health Technology Co in Q1 2024 and held it in 4 quarters.
  • Rivernorth Capital Management's Aimei Health Technology Co position peaked at $1.83M in Q4 2024.
  • 16 funds tracked by Wall St. Rank held Aimei Health Technology Co as of Q1 2025.

Based on Rivernorth Capital Management's 13F filing for Q1 2025, filed 15 May 2025.